The current status of T-cell depleted allogeneic stem-cell transplants in adult patients with AML

Cytotherapy. 2001;3(3):175-88. doi: 10.1080/146532401753174007.
No abstract available

Publication types

  • Review

MeSH terms

  • Acquired Immunodeficiency Syndrome / drug therapy
  • Acquired Immunodeficiency Syndrome / immunology
  • Acquired Immunodeficiency Syndrome / prevention & control
  • Adult
  • Graft vs Host Disease / drug therapy
  • Graft vs Host Disease / immunology
  • Graft vs Host Disease / prevention & control*
  • Humans
  • Immunosuppression Therapy / adverse effects
  • Immunosuppression Therapy / methods*
  • Immunosuppression Therapy / trends
  • Leukemia, Myeloid, Acute / immunology
  • Leukemia, Myeloid, Acute / physiopathology
  • Leukemia, Myeloid, Acute / therapy*
  • Lymphoproliferative Disorders / immunology
  • Lymphoproliferative Disorders / physiopathology
  • Lymphoproliferative Disorders / prevention & control
  • Recurrence
  • Stem Cell Transplantation / adverse effects
  • Stem Cell Transplantation / methods*
  • Stem Cell Transplantation / trends
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / immunology
  • Transplantation Conditioning / adverse effects
  • Transplantation Conditioning / methods*
  • Transplantation Conditioning / trends
  • Transplantation, Homologous / adverse effects
  • Transplantation, Homologous / methods*
  • Transplantation, Homologous / trends
  • Treatment Failure